FRES Fresh2 Group: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Fresh2 Group Limited (FRES) relies on a Chinese B2B supply system with a powerful network effect, while IT services for product distribution ensure stable cash flows. This chart on GURU.Markets captured the metric. The company is currently undergoing a global transformation, pivoting from laboratory diagnostics to a digital e-commerce and logistics platform for agricultural products.
Financial and market metric breakdowns for fresh2.co (FRES)
- stock price and consensus target price:
- company stock capitalization data:
- book value of equity indicators:
- company liabilities and liquidity data:
- financial results and valuation multiples details:
FRES - Final Profit|Expected Profit Fresh2 Group Limited|FRES - Price to Earnings Ratio|Future Price to Earnings Multiple Fresh2 Group|FRES - PEG Multiple|Enterprise Value to EBITDA Multiple Fresh2 Group Limited|FRES - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Fresh2 Group|FRES - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months fresh2.co|FRES - Net earnings per share growth this year|Earnings growth forecast for next year Fresh2 Group Limited
Summary company analysis:Fresh2 FRES
Fresh2 Group Limited (FRES) integrates IT platforms into China's agricultural sector, combining logistics and e-commerce. The EV/EBITDA metric relates the total enterprise value to operating profit before depreciation and taxes, allowing for an objective assessment of a capital-intensive business with debt leverage. By analyzing the business valuation level via EV/EBITDA, an investor separates market noise from fundamental value, determining the extent to which the asset is overbought or undervalued.
Competitor analysis
Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|OPK: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|Business Value to Operating Income Before Depreciation MRVI|Fulgent Corp - EV/EBITDA Multiple|Company Value to EBITDA Standard BioTools Corp|Cytek Biosciences, Inc. (CTKB) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|OSUR - Total Company Value to Operating Income Before Depreciation Ratio|XGN (Exagen Inc) - EV/EBITDA Multiple|MDXH: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lucid Diagnostics Inc (LUCD)|Enterprise Value to EBITDA Ratio prenetics.com PRE|Business Value to Operating Income Before Depreciation Insight Molecular Diagnostics Inc|EV/EBITDA Multiple Trinity Biotech PLC TRIB|Enterprise Value to EBITDA Multiple PRPH|AIMD: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation Co-Diagnostics Corp CODX|HSCS (Heart Test Labs) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA BMRA (Biomerica, Inc.)|Enterprise Value to EBITDA Ratio Cardio Diagnostics Holdings, Inc. (CDIO)|EV/EBITDA Multiple ONCO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VRAX (Virax Biolabs Group Limited)|Bluejay (BJDX) - Company Value to Operating Income Before Depreciation Ratio|AWH - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation Accelerate Diagnostics (AXDX)|CNTG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|enzo.com (ENZ) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Genetic Technologies Limited (GENE) - EV/EBITDA Multiple|ME: Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PMD
